Tina Bhutani-Jacques, MD, presents the case of a 28-year old male with atopic dermatits, wherein the patient attributes his flares to his housing conditions. She discusses the role of patient counseling, shared decision making, and sustained disease control in the management of patients suffering from this condition.
Experts in dermatology share insights on considering the location's impact in treating plaque psoriasis, focusing on challenges with scalp involvement and addressing limitations with topical therapies.
Lisa Swanson, MD, FAAD and Robert J. Casquejo, PA-C highlight the impact of plaque psoriasis on both moderate and mild patients, emphasizing the importance of addressing these concerns in patient care.
An expert in skin condition management discusses the case of a 13-year-old male with a prolonged history of AD and early-onset food allergies. Emphasizing the challenges of the steroid treatment cycle, the expert provides insights into integrating parental preferences for "natural" agents alongside effective pharmaceutical options. Additionally, the discussion explores strategies for communicating treatment mechanisms to patients and fostering collaborative engagement in the treatment selection process.
TJ Chao, MPAS, PA-C, examines the case of an 18-year-old female with persistent AD, wherein the patient attributes her flares to her housing conditions. He discusses her treatment plan and addresses the challenges posed by red face syndrome induced by dupilumab, while commenting on how the panel managed patient expectations, treatment preferences, and sustained disease control.
Raj Chovatiya, MD, PhD, and Adelaide A. Hebert, MD, FAAD, comment on the newer treatments in AD, highlighting the positive impact these agents have had in managing the disease.
Raj Chovatiya, MD, PhD, and Adelaide A. Hebert, MD, FAAD, discuss the current treatment landscape of atopic dermatitis (AD), as well as key factors when selecting treatment for patients with the disease.
Dr Lal, an expert in dermatology, presents the case of a 45-year-old female with a history of childhood AD marked by severe symptoms. He recaps a panel conversation on the approach to treatment, emphasizing the importance of initiating effective and long-lasting treatment options for optimal relief.
Karan Lal, DO, MS, FAAD, discusses a case involving a 4-year-old male with atopic dermatitis, covering FDA-approved treatments for this age group, strategies for tapering and stopping treatment, the impact of the atopic march, and challenges with treatment prior authorizations.
An expert in the management of skin conditions provides an overview of a 20-year-old male diagnosed with atopic dermatitis, discussing key insights from a round table discussion. The conversation focused on effective management strategies, best practices for prior authorization approvals, and the significance of treatment vehicles.
Monica Harilall, PA-C, MMS, delves into the case of an 18-year-old female with atopic dermatitis, highlighting the challenges in managing adolescent patients who are self-conscious about their condition and seek rapid results. The discussion explores effective ways to communicate treatment mechanisms to patients and engage them collaboratively in the treatment selection process.
Benjamin Lockshin, MD, FAAD, summarizes the panel's best practices for improving patient education on the risks and benefits of vitiligo treatment. He underscores the importance of establishing and managing expectations for treatment response.
An expert in dermatology discusses the case of an active 71-year-old female who spends considerable time outdoors. The expert summarizes the panel's recommendations for counseling the patient on the benefits of treatment compliance and the use of sun-sparing products to enhance her quality of life and treatment response.
Benjamin Lockshin, MD, FAAD, summarizes key points from a panel discussion on the utilization of topical treatments in vitiligo. The first case revolves a 31-year-old woman with distressing depigmentation and highlights the panel's treatment approach to the management of this condition in difficult to treat areas.
An expert in dermatology discusses the case of an active 62-year-old female, who is self-conscious about her condition, and explores how the panel would advise her to maintain her outdoor lifestyle while discussing effective topical treatments.
Heather C Woolery-Lloyd, MD, discusses a 23-year-old woman with vitiligo vulgaris affecting 75% of her face, including complete depigmentation. She explores the panel’s response to managing progressive disease and its impact on the patient's quality of life.
Dr Darrel Rigel provides insights into cutting-edge photoprotection strategies, emphasizing the specific considerations for skin of color patients and the critical role of sunscreen in preventive dermatology.
Darrel Rigel, MD, MS, sheds light on the rationale behind broad-spectrum sunscreens, emphasizing the imperative protection against UV radiation and the significance of both organic and inorganic sunscreen compounds.
Saranya Wyles, MD, PhD, offers guidance on integrating advanced skincare technologies into their practices and the importance of staying updated through events like the Science of Skincare summit.
An expert in dermatology delves into the latest breakthroughs in antioxidants' role in anti-aging and receive expert guidance on seamlessly integrating these innovative approaches into your daily skincare regimen.
Saranya Wyles, MD, PhD, explores the science behind successful skincare products, focusing on key ingredients like retinoids and alpha hydroxy acids and their role in effective formulations across OTC and prescription products.
Dr Omar Noor delves into the complexities of boxed warnings tied to JAK inhibitors, contrasting their presence in systemic forms with the absence in the oral version of topical ruxolitinib, and discusses the potential impact on dialogues with both patients and fellow healthcare providers. He further underscores the pivotal role of long-standing safety data in building provider confidence in a treatment.
Omar Noor, MD, FAAD, discusses the critical role of patient education and transparent communication in the context of treating individuals with atopic dermatitis. He emphasizes the significance of cultivating trust in patient-provider relationships, explores the potential necessity of shifting the treatment paradigm, and addresses the implications of treatment interruptions or transitions in the long-term management of this condition, all while considering the crucial aspect of access to care.
Dr Adelaide A. Hebert discusses pediatric acne management, early onset trends, and the future of acne care.
Adelaide A. Hebert, MD, FAAD, shares her commentary on advancements in acne management, highlighting advancements in the pathophysiology, benefits of multimodal treatment approaches, and the role of retinoids.
An expert in dermatology presents the case of a 58-year-old male who has struggled with long-standing atopic dermatitis. The presentation delves into the considerations between topical and systemic treatments and sheds light on the intricacies of managing patients with comorbidities, extensive treatment histories, and the challenges posed by prior authorizations.
Ted Lain, MD & MBA, FAAD, provides an overview of a roundtable discussion centered around a challenging case of a 28-year-old female experiencing recurrent flaring atopic dermatitis. He shares insights from a panel of dermatologists regarding their recommended treatment approach, emphasizing the incorporation of a novel topical treatment to achieve enduring disease remission.
Experts in dermatological conditions provide insight on challenges patients and clinicians may face in accessing vitiligo medications, especially for newer therapies, and the future of vitiligo treatment.
Susan C. Taylor, MD, and George Han, MD, PhD, discuss how to measure treatment response in patients with vitiligo and share advice for counseling patients about long-term use and compliance of treatment.
An expert in dermatology discusses the intricacies of addressing anti-aging concerns in patients with diverse skin tones, emphasizing the importance of tailoring management to meet their unique needs, understanding the underlying mechanisms of aging, and appreciating the cultural nuances within patient populations.
